自己株式の処分、Retirement Of Treasury Stock、Transfer To Capital Surplus From Retained Earnings他1件
- 【期間】
年度 | 自己株式の処分 | Retirement Of Treasury Stock | Transfer To Capital Surplus From Retained Earnings | 減損損失 - 医薬 |
---|
2018/12 | - | | - | | - | | 9.52億 | |
2019/12 | - | | - | | - | | 63.9億 | +571.6% |
2020/12 | - | | - | | - | | 28.6億 | -55.3% |
2021/12 | - | | - | | - | | 52.9億 | +85% |
2022/12 | - | | - | | - | | 180億 | +240.1% |
2023/12 | - | | - | | - | | 108億 | -39.7% |